Guofeng Ji

458 total citations
23 papers, 371 citations indexed

About

Guofeng Ji is a scholar working on Oncology, Biomedical Engineering and Immunology. According to data from OpenAlex, Guofeng Ji has authored 23 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Biomedical Engineering and 5 papers in Immunology. Recurrent topics in Guofeng Ji's work include Cancer Immunotherapy and Biomarkers (7 papers), Nanoplatforms for cancer theranostics (7 papers) and Immunotherapy and Immune Responses (5 papers). Guofeng Ji is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Nanoplatforms for cancer theranostics (7 papers) and Immunotherapy and Immune Responses (5 papers). Guofeng Ji collaborates with scholars based in China, United States and New Zealand. Guofeng Ji's co-authors include Xinghui Si, Wantong Song, Zhaohui Tang, Sheng Ma, Xuedong Fang, Haochen Yao, Chong Ma, Jiayu Zhao, Yudi Xu and Xuesi Chen and has published in prestigious journals such as Advanced Materials, Nano Letters and Advanced Drug Delivery Reviews.

In The Last Decade

Guofeng Ji

21 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guofeng Ji China 10 160 145 135 81 79 23 371
Deby Fajar Mardhian Netherlands 7 98 0.6× 139 1.0× 61 0.5× 84 1.0× 68 0.9× 8 336
Sun Hwa Kim South Korea 10 71 0.4× 164 1.1× 171 1.3× 128 1.6× 52 0.7× 25 453
Jiaai Wang United States 9 90 0.6× 78 0.5× 154 1.1× 156 1.9× 33 0.4× 15 386
Young Seok Cho South Korea 12 119 0.7× 76 0.5× 103 0.8× 167 2.1× 87 1.1× 27 411
Yohana C. Toner United States 5 69 0.4× 119 0.8× 127 0.9× 100 1.2× 64 0.8× 7 341
Yoshihiko Kakiuchi Japan 9 42 0.3× 154 1.1× 86 0.6× 118 1.5× 36 0.5× 38 361
Junjie Fang China 8 114 0.7× 90 0.6× 104 0.8× 174 2.1× 52 0.7× 16 468
Seung Mo Jin South Korea 7 235 1.5× 116 0.8× 293 2.2× 119 1.5× 79 1.0× 11 435
Qianqian Zhu China 5 340 2.1× 74 0.5× 139 1.0× 230 2.8× 207 2.6× 14 584
Zhenhu He China 8 97 0.6× 52 0.4× 72 0.5× 45 0.6× 32 0.4× 17 254

Countries citing papers authored by Guofeng Ji

Since Specialization
Citations

This map shows the geographic impact of Guofeng Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guofeng Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guofeng Ji more than expected).

Fields of papers citing papers by Guofeng Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guofeng Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guofeng Ji. The network helps show where Guofeng Ji may publish in the future.

Co-authorship network of co-authors of Guofeng Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Guofeng Ji. A scholar is included among the top collaborators of Guofeng Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guofeng Ji. Guofeng Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Baozhen, Min Li, Xinghui Si, et al.. (2025). A syringeable immunotherapeutic hydrogel enhances T cell immunity via in-situ activation of STING pathway for advanced breast cancer postoperative therapy. Frontiers in Immunology. 16. 1523436–1523436. 2 indexed citations
3.
Ji, Guofeng, et al.. (2024). Targeting bacterial metabolites in tumor for cancer therapy: An alternative approach for targeting tumor-associated bacteria. Advanced Drug Delivery Reviews. 211. 115345–115345. 10 indexed citations
4.
Liu, Yangwei, et al.. (2024). Passive control of flow separation with blade-end slots for a three-stage compressor at different Reynolds numbers. Aerospace Science and Technology. 155. 109742–109742. 6 indexed citations
5.
6.
Si, Xinghui, Guofeng Ji, Sheng Ma, et al.. (2024). Minimally Invasive Injectable Gel for Local Immunotherapy of Liver and Gastric Cancer. Advanced Science. 11(38). e2405935–e2405935. 6 indexed citations
7.
Sun, Lu, Jun Qi, Lei Ding, et al.. (2024). Ultrasound-triggered nano delivery of lenvatinib for selective immunotherapy treatment against hepatocellular carcinoma. Scientific Reports. 14(1). 27395–27395. 6 indexed citations
8.
Liu, Hongyu, et al.. (2024). Ultrasound-triggered with ROS-responsive SN38 nanoparticle for enhanced combination cancer immunotherapy. Frontiers in Immunology. 15. 1339380–1339380. 5 indexed citations
9.
Wang, Zhanfeng, et al.. (2024). Biopolymer immune implants co-loaded with TMZ, R848 and IOX1 for perioperative therapy of glioblastoma. Acta Biomaterialia. 189. 143–154. 2 indexed citations
10.
Si, Xinghui, Guofeng Ji, Sheng Ma, et al.. (2024). Safety evaluation of biopolymer immune implants in rats and rabbits as well as therapeutic effects on gastric cancer peritoneal metastasis carcinoma. Science China Materials. 67(7). 2080–2089. 4 indexed citations
11.
Si, Xinghui, Guofeng Ji, Sheng Ma, et al.. (2022). Comprehensive evaluation of biopolymer immune implants for peritoneal metastasis carcinoma therapy. Journal of Controlled Release. 353. 289–302. 18 indexed citations
12.
Yao, Haochen, Na Shen, Guofeng Ji, et al.. (2022). Cisplatin Nanoparticles Promote Intratumoral CD8+ T Cell Priming via Antigen Presentation and T Cell Receptor Crosstalk. Nano Letters. 22(8). 3328–3339. 24 indexed citations
13.
Yu, Zhentao, Yudi Xu, Haochen Yao, et al.. (2021). A simple and general strategy for postsurgical personalized cancer vaccine therapy based on an injectable dynamic covalent hydrogel. Biomaterials Science. 9(20). 6879–6888. 19 indexed citations
14.
Ji, Guofeng, Xinghui Si, Dong Si, et al.. (2021). Manipulating Liver Bile Acid Signaling by Nanodelivery of Bile Acid Receptor Modulators for Liver Cancer Immunotherapy. Nano Letters. 21(16). 6781–6791. 35 indexed citations
15.
Si, Xinghui, Guofeng Ji, Sheng Ma, et al.. (2021). In–Situ‐Sprayed Dual‐Functional Immunotherapeutic Gel for Colorectal Cancer Postsurgical Treatment. Advanced Healthcare Materials. 10(20). e2100862–e2100862. 36 indexed citations
16.
Si, Xinghui, Guofeng Ji, Sheng Ma, et al.. (2020). Biodegradable Implants Combined with Immunogenic Chemotherapy and Immune Checkpoint Therapy for Peritoneal Metastatic Carcinoma Postoperative Treatment. ACS Biomaterials Science & Engineering. 6(9). 5281–5289. 20 indexed citations
17.
Ji, Guofeng, et al.. (2020). The impact of anastomotic leakage on oncology after curative anterior resection for rectal cancer. Medicine. 99(37). e22139–e22139. 20 indexed citations
18.
Ji, Guofeng, Haochen Yao, Sheng Ma, et al.. (2020). Precise delivery of obeticholic acid via nanoapproach for triggering natural killer T cell-mediated liver cancer immunotherapy. Acta Pharmaceutica Sinica B. 10(11). 2171–2182. 53 indexed citations
19.
Li, Zhihui, Juan Du, Qianfeng Zhang, Guofeng Ji, & Hongwu Zhang. (2020). A study of fan-distortion interaction within the fan rotor. Proceedings of the Institution of Mechanical Engineers Part A Journal of Power and Energy. 235(2). 185–201. 2 indexed citations
20.
Ji, Guofeng, Yu Zhang, Xinghui Si, et al.. (2020). Biopolymer Immune Implants’ Sequential Activation of Innate and Adaptive Immunity for Colorectal Cancer Postoperative Immunotherapy. Advanced Materials. 33(3). e2004559–e2004559. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deby Fajar Mardhian Breakdown of academic impact, for papers by Sun Hwa Kim Breakdown of academic impact, for papers by Jiaai Wang Breakdown of academic impact, for papers by Young Seok Cho Breakdown of academic impact, for papers by Yohana C. Toner Breakdown of academic impact, for papers by Yoshihiko Kakiuchi Breakdown of academic impact, for papers by Junjie Fang Breakdown of academic impact, for papers by Seung Mo Jin Breakdown of academic impact, for papers by Qianqian Zhu Breakdown of academic impact, for papers by Zhenhu He
Rankless by CCL
2026